A study to explore the correlation of trough level concentration and ABCB1, OCT1, ABCG2 genetic polymorphisms with imatinib mesylate induced thrombocytopenia in chronic myeloid leukemia patients

Authors :: Suresh Chandra Pradhan
Adithan Chandrasekaran
Rajan Sundaram
Jose Francis
Dubashi Biswajit
Source :: Journal of Clinical Oncology. 33:e13564-e13564
Publication Year :: 2015
Publisher :: American Society of Clinical Oncology (ASCO), 2015.
Abstract: e13564 Background: Imatinib mesylate is presently the first line treatment for chronic myeloid leukemia (CML). Therapeutic drug monitoring (TDM) and pharmacogenetic screening is warranted for bette...

Full Text Access

Tools